Product Information
PRAVASTATIN SODIUM 40 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0828 per EA under NDC 68462019790. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462019790
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAVASTATIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077987FDA Approved
5/11/2007
TE Code
AB
On Market Since
5/11/2007
Pharmacological Classes
Price Statistics
The NADAC for PRAVASTATIN SODIUM 40 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0828 per EA |
|---|---|
| All-time high | $0.6706 (Jan 15, 2014) |
| All-time low | $0.0684 (Nov 20, 2024) |
| 52-week high | $0.0901 |
| 52-week low | $0.0828 |
| Median price | $0.1008 |
| Average price | $0.1804 |
| Largest weekly change | +31.2% (Dec 18, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pravastatin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAVASTATIN SODIUM 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 40 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0828 per EA (NDC 68462019790), effective Sep 30, 2026.
How has the price of PRAVASTATIN SODIUM 40 MG TAB changed over time?
Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 40 MG TAB has declined 83.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 40 MG TAB?
Since Nov 28, 2013, the NADAC for PRAVASTATIN SODIUM 40 MG TAB has ranged from a low of $0.0684 (Nov 20, 2024) to a high of $0.6706 (Jan 15, 2014), with a median of $0.1008 per EA.
Are there cheaper alternatives to PRAVASTATIN SODIUM 40 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAVASTATIN SODIUM 40 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAVASTATIN SODIUM 40 MG TAB?
PRAVASTATIN SODIUM 40 MG TAB (NDC 68462019790) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.